Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialRoland E. Schmieder, Murray Esler, Henry Krum et al.|The Lancet|2010Cited by 2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort studyHenry Krum, Murray Esler, Markus P. Schlaich et al.|The Lancet|2009Cited by 2.1k
Renal Sympathetic-Nerve Ablation for Uncontrolled HypertensionMarkus P. Schlaich, Murray Esler, Paul A. Sobotka et al.|New England Journal of Medicine|2009Cited by 774
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 studyHenry Krum, Murray Esler, Markus P. Schlaich et al.|The Lancet|2013Cited by 622
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant HypertensionFelix Mahfoud, Michael Böhm, Oliver Vonend et al.|Circulation|2011Cited by 569